Fig. 3
From: Efficacy & safety of brolucizumab 6.0 mg versus 3.6 mg in diabetic macular edema
Meant CMT on OCT between both the groups at each week
Fig. 3 | International Journal of Retina and Vitreous
From: Efficacy & safety of brolucizumab 6.0 mg versus 3.6 mg in diabetic macular edema
Meant CMT on OCT between both the groups at each week